Porphyria
MONDO:0037939Porphyria is a group of diseases in which substances called porphyrins build up, negatively affecting the skin or nervous system. Most types are inherited, but porphyria cutanea tarda may also be due to increased iron in the liver, hepatitis C, alcohol, or HIV/AIDS.
Also known as: porphyria
25 clinical trials for this condition and its sub-types, 8 tagged with Porphyria itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Porphyria
-
Inherited porphyria 0 trials · 24 incl. sub-types
9 sub-types
- Erythropoietic protoporphyria 15 trials Sub-types →
- CPOX-related hereditary coproporphyria 0 trials · 5 incl. sub-types Sub-types →
- HMBS-related hepatic porphyria 0 trials · 5 incl. sub-types Sub-types →
- PPOX-related hepatic porphyria 0 trials · 2 incl. sub-types Sub-types →
- Cutaneous porphyria 2 trials
- UROD-related inherited porphyria 0 trials · 1 incl. sub-types Sub-types →
- Chester porphyria 0 trials
- Erythropoietic uroporphyria associated with myeloid malignancy 0 trials
- Porphyria due to ALA dehydratase deficiency 0 trials
-
Hepatic porphyria 4 trials · 23 incl. sub-types
7 sub-types
- Erythropoietic protoporphyria 15 trials Sub-types →
- HMBS-related hepatic porphyria 0 trials · 5 incl. sub-types Sub-types →
- Hereditary coproporphyria 5 trials
- PPOX-related hepatic porphyria 0 trials · 2 incl. sub-types Sub-types →
- Porphyria cutanea tarda 0 trials · 1 incl. sub-types Sub-types →
- Hepatic cutaneous porphyria 0 trials
- Porphyria due to ALA dehydratase deficiency 0 trials
-
Acquired porphyria 0 trials
1 sub-type
- Sporadic porphyria cutanea tarda 0 trials
Most studied deeper sub-types
-
New drug offers hope for patients who Can't tolerate sunlight
Disease control CompletedThis study tested a drug called bitopertin in 75 adults with erythropoietic protoporphyria (EPP), a rare condition that causes severe pain from sunlight exposure. The goal was to see if the drug is safe and can lower levels of a harmful substance in the blood. Participants receiv…
Phase 2 • Sponsor: Disc Medicine, Inc • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC
-
New laser shows promise for wrinkle reduction in clinical trial
Symptom relief CompletedThis study tested a laser device (NIRA Laser M2.1) on 120 adults aged 35 and older to see if it could safely reduce full-face wrinkles. Some participants also used a topical cream after the laser. Wrinkle improvement was judged by experts looking at before-and-after photos, and p…
Sponsor: NIRA Innovations Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 12:31 UTC